| David Dalton, DO | |
|
700 N Spring St, Caliente, NV 89008-1010 | |
| (775) 726-3171 | |
| (775) 726-3797 |
| Full Name | David Dalton |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 700 N Spring St, Caliente, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659755320 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2015020391 (Missouri) | Secondary |
| 207Q00000X | Family Medicine | DO2594 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Desert View Home Health Inc | Las vegas, NV | Home health agency |
| Grover C Dils Medical Center | Caliente, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lincoln County Hospital District | 2163408246 | 7 |
| Knee Regeneration And Advanced Healthcare Of St George | 6709250988 | 6 |
| Lincoln County Hospital District | 2163408246 | 7 |
News Archive
In an article published in the journal Virus Research, a team of researchers from various US institutions discussed their study that evaluated the antiviral activity of PTC299 against a group of RNA viruses in vitro.
Entos Pharmaceuticals, a healthcare biotechnology company developing nucleic acid medicines with its Fusogenix drug delivery platform, today announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA vaccine from its prototyping program launched at the onset of the global COVID-19 pandemic.
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD), announced today it has closed a Series E financing totaling $31 million.
Oregon Health & Science University Cancer Institute researchers have found that a tumor protein present in an aggressive form of breast cancer is related to a poor prognosis.
› Verified 2 days ago
| Entity Name | Lincoln County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659423341 PECOS PAC ID: 2163408246 Enrollment ID: O20040629000192 |
News Archive
In an article published in the journal Virus Research, a team of researchers from various US institutions discussed their study that evaluated the antiviral activity of PTC299 against a group of RNA viruses in vitro.
Entos Pharmaceuticals, a healthcare biotechnology company developing nucleic acid medicines with its Fusogenix drug delivery platform, today announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA vaccine from its prototyping program launched at the onset of the global COVID-19 pandemic.
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD), announced today it has closed a Series E financing totaling $31 million.
Oregon Health & Science University Cancer Institute researchers have found that a tumor protein present in an aggressive form of breast cancer is related to a poor prognosis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Dalton, DO Po Box 1010, Caliente, NV 89008-1010 Ph: (775) 726-3171 | David Dalton, DO 700 N Spring St, Caliente, NV 89008-1010 Ph: (775) 726-3171 |
News Archive
In an article published in the journal Virus Research, a team of researchers from various US institutions discussed their study that evaluated the antiviral activity of PTC299 against a group of RNA viruses in vitro.
Entos Pharmaceuticals, a healthcare biotechnology company developing nucleic acid medicines with its Fusogenix drug delivery platform, today announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA vaccine from its prototyping program launched at the onset of the global COVID-19 pandemic.
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD), announced today it has closed a Series E financing totaling $31 million.
Oregon Health & Science University Cancer Institute researchers have found that a tumor protein present in an aggressive form of breast cancer is related to a poor prognosis.
› Verified 2 days ago
Michael Sean Luedeman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 N Spring St., Caliente, NV 89008 Phone: 775-726-3171 Fax: 775-726-3797 | |
Mr. Richard William Katschke Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 North Spring Street, Caliente, NV 89008 Phone: 775-726-3121 Fax: 775-726-3666 | |
John Russell Rogers, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 N Spring St, #a, Caliente, NV 89008 Phone: 775-726-3121 Fax: 775-726-3666 |